---
figid: PMC6523117__cells-08-00355-g007
figtitle: Suggested mechanism of rFlaA:Betv1-mediated mDC activation
organisms:
- NA
pmcid: PMC6523117
filename: cells-08-00355-g007.jpg
figlink: /pmc/articles/PMC6523117/figure/cells-08-00355-f007/
number: F7
caption: Suggested mechanism of rFlaA:Betv1-mediated mDC activation. Stimulation of
  mDCs with rFlaA:Betv1 results in enhanced uptake of the fusion protein and a mammalian
  target of rapamycin (complex 1) (mTORC1)-dependent activation of mDC metabolism
  and immune modulatory IL-10 secretion, likely mediated by hypoxia-inducible factor
  1-alpha (HIF-1α)- and avian myelocytomatosis virus oncogene cellular homology (c-Myc)-
  and signal transducer/activator of transcription 3 (STAT-3)-signaling, respectively
  (1). rFlaA:Betv1 also triggers a myeloid differentiation primary response 88 (MyD88)-dependent,
  interleukin-1 receptor-associated kinase 1 (IRAK1)/IRAK4/TNF receptor associated
  factor 6 (TRAF6)/transforming growth factor beta-activated kinase 1 (TAK1)-mediated
  activation of the MAP kinase signaling pathway (2). Once activated, MAPK-signaling
  can cross-trigger activation and nuclear translocation of NFκB via TAK1-mediated
  activation of IKKα (3). Here, both NFκB- (promoting IL-12 secretion) and MAP kinase-signaling
  (promoting IL-6 and TNF-α secretion) contribute to rFlaA:Betv1-induced pro-inflammatory
  cytokine secretion. In addition, the activation of MAP kinase signaling can cross-activate
  the mTOR pathway by either inhibiting tuberous sclerosis complex 1/2 (TSC-1/TSC-2)
  complexes, phosphorylation of regulatory associated protein of mTOR (RAPTOR), or
  direct activation of mTOR downstream targets like p70 S6 kinase by ERK/ribosomal
  S6 kinase (RSK) (4). The MAPK-dependent mTOR activation also contributes to IL-10
  secretion while contributing to rFlaA:Betv1-induced activation of mDC metabolism
  via JNK MAPK activation. The different inhibitors used in this study are indicated
  in orange, orange arrows depict inhibitory signals, black arrows depict activating
  signals.
papertitle: 'NFκB- and MAP-Kinase Signaling Contribute to the Activation of Murine
  Myeloid Dendritic Cells by a Flagellin A: Allergen Fusion Protein.'
reftext: Tobias Moeller, et al. Cells. 2019 Apr;8(4):355.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9549732
figid_alias: PMC6523117__F7
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC6523117__F7
ndex: a645bbd8-deeb-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6523117__cells-08-00355-g007.html
  '@type': Dataset
  description: Suggested mechanism of rFlaA:Betv1-mediated mDC activation. Stimulation
    of mDCs with rFlaA:Betv1 results in enhanced uptake of the fusion protein and
    a mammalian target of rapamycin (complex 1) (mTORC1)-dependent activation of mDC
    metabolism and immune modulatory IL-10 secretion, likely mediated by hypoxia-inducible
    factor 1-alpha (HIF-1α)- and avian myelocytomatosis virus oncogene cellular homology
    (c-Myc)- and signal transducer/activator of transcription 3 (STAT-3)-signaling,
    respectively (1). rFlaA:Betv1 also triggers a myeloid differentiation primary
    response 88 (MyD88)-dependent, interleukin-1 receptor-associated kinase 1 (IRAK1)/IRAK4/TNF
    receptor associated factor 6 (TRAF6)/transforming growth factor beta-activated
    kinase 1 (TAK1)-mediated activation of the MAP kinase signaling pathway (2). Once
    activated, MAPK-signaling can cross-trigger activation and nuclear translocation
    of NFκB via TAK1-mediated activation of IKKα (3). Here, both NFκB- (promoting
    IL-12 secretion) and MAP kinase-signaling (promoting IL-6 and TNF-α secretion)
    contribute to rFlaA:Betv1-induced pro-inflammatory cytokine secretion. In addition,
    the activation of MAP kinase signaling can cross-activate the mTOR pathway by
    either inhibiting tuberous sclerosis complex 1/2 (TSC-1/TSC-2) complexes, phosphorylation
    of regulatory associated protein of mTOR (RAPTOR), or direct activation of mTOR
    downstream targets like p70 S6 kinase by ERK/ribosomal S6 kinase (RSK) (4). The
    MAPK-dependent mTOR activation also contributes to IL-10 secretion while contributing
    to rFlaA:Betv1-induced activation of mDC metabolism via JNK MAPK activation. The
    different inhibitors used in this study are indicated in orange, orange arrows
    depict inhibitory signals, black arrows depict activating signals.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Myd88
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Traf6
  - ras
  - Ras64B
  - Ras85D
  - Akt
  - Tak1
  - Tsc1
  - Sc2
  - Dsor1
  - Mtk
  - MKP-4
  - p38b
  - rl
  - PRAS40
  - raptor
  - Mtor
  - Tor
  - Rap1
  - fzr
  - bsk
  - lic
  - Nurf-38
  - Ebp
  - AIMP2
  - p38a
  - Hrb87F
  - p38c
  - Taf9
  - Arpc1
  - Ssl1
  - S6k
  - WDR79
  - tral
  - rump
  - MED17
  - SF1
  - Irbp
  - S6kII
  - Dif
  - dl
  - Rel
  - CrebB
  - CrebA
  - AP-1gamma
  - Jra
  - kay
  - sima
  - Myc
  - egr
  - TLR5
  - MYD88
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - IRAK1
  - IRAK4
  - TRAF6
  - KRAS
  - HRAS
  - NRAS
  - AKT1
  - AKT2
  - AKT3
  - CHUK
  - MAP3K7
  - NR2C2
  - CCL26
  - TECR
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - AKT1S1
  - MTOR
  - LRPAP1
  - APCS
  - SH2D1A
  - CRK
  - GRAP2
  - AHSA1
  - POLDIP2
  - PSMC6
  - CDKL1
  - CDK20
  - NUP43
  - H3P30
  - GTF2H2
  - IFI44
  - WDR77
  - H3P33
  - RPS6KB1
  - RPS6KB2
  - ANXA6
  - UBASH3B
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - STAT3
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - FOSL1
  - FOSL2
  - HIF1A
  - MYC
  - IL10
  - IL6
  - IL12A
  - IL12B
  - TNF
  - MTG1
  - U0126
  - Cancer
---
